1 |
Lu Y, Zhang W, Li H, Liu C, Gao D, Zhuang J, Liu R, Wu J, Sun C. The Mechanism of Quercetin in the Treatment of Lung Squamous Cell Carcinoma Based on a Protein-Protein Interaction Network. Evid Based Complement Alternat Med 2022;2022:9985160. [PMID: 36605099 DOI: 10.1155/2022/9985160] [Reference Citation Analysis]
|
2 |
Li Q, He J, Li S, Tian C, Yang J, Yuan H, Lu Y, Fagone P, Nicoletti F, Xiang M. The combination of gemcitabine and ginsenoside Rh2 enhances the immune function of dendritic cells against pancreatic cancer via the CARD9-BCL10-MALT1 / NF-κB pathway. Clin Immunol 2022;:109217. [PMID: 36581220 DOI: 10.1016/j.clim.2022.109217] [Reference Citation Analysis]
|
3 |
Li J, Wang L, Yu X, Guan Y, Wang X. Panaxadiol targeting IL2 inducible T cell kinase promotes T cell immunity in radiotherapy. Anticancer Drugs 2022. [PMID: 36730497 DOI: 10.1097/CAD.0000000000001448] [Reference Citation Analysis]
|
4 |
Zhang J, Han H, Wang L, Wang W, Yang M, Qin Y. Overcoming the therapeutic resistance of hepatomas by targeting the tumor microenvironment. Front Oncol 2022;12. [DOI: 10.3389/fonc.2022.988956] [Reference Citation Analysis]
|
5 |
Ni B, Song X, Shi B, Wang J, Sun Q, Wang X, Xu M, Cao L, Zhu G, Li J. Research progress of ginseng in the treatment of gastrointestinal cancers. Front Pharmacol 2022;13:1036498. [DOI: 10.3389/fphar.2022.1036498] [Reference Citation Analysis]
|
6 |
Wu H, Ganguly S, Tollefsbol TO. Modulating Microbiota as a New Strategy for Breast Cancer Prevention and Treatment. Microorganisms 2022;10:1727. [DOI: 10.3390/microorganisms10091727] [Reference Citation Analysis]
|
7 |
Zhou J, Wang L, Peng C, Peng F. Co-Targeting Tumor Angiogenesis and Immunosuppressive Tumor Microenvironment: A Perspective in Ethnopharmacology. Front Pharmacol 2022;13:886198. [DOI: 10.3389/fphar.2022.886198] [Reference Citation Analysis]
|